Specialty Pharmacy

By Dean P. Erhardt

Alzheimer’s Researchers Receive NIH Grant to Test Intranasal Insulin Spray

Researchers will receive $7.9 million over the next 5 years to test the effects of intranasal insulin therapy on patients with mild cognitive impairment and mild to moderate Alzheimer’s disease.

> Read Full Article

Surya Singh, MD, Addresses Ways to Manage Oncology Spending in Specialty Pharmacy

In this AJMC video, Surya Singh, MD, Vice President, Medical Benefit Management, CVS Caremark, discusses a variety of approaches used to stem the rise of costs associated with oncology.

> Read Full Article

Obama Administration Announces National Plan to Address Alzheimer’s Disease

The plan marks the creation of a landmark national strategy to increase public awareness of Alzheimer’s disease.

> Read Full Article

Dietary Interventions Prevent Dyslipidemia in Patients Started on HAART

HIV

Although the use of highly active antiretroviral therapy (FC) has greatly reduced the morbidity and mortality of patients infected with HIV, it is also associated with the development of adverse effects, particularly metabolic disorders like dyslipidemia.

> Read Full Article

Lundbeck, Inc’s Onfi

The FDA approved Lundbeck, Inc's Onfi (clobazam) as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in patients that are 2 years and older.

> Read Full Review